Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 2
1983 2
1985 2
1986 2
1987 11
1988 5
1989 1
1990 2
1991 3
1992 3
1993 2
1994 3
1995 5
1996 2
1997 3
1998 2
1999 3
2000 5
2001 3
2002 3
2003 2
2004 6
2005 6
2006 4
2007 4
2008 1
2009 1
2012 2
2013 1
2014 1
2015 1
2016 1
2018 1
2019 2
2020 1
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

98 results

Results by year

Filters applied: . Clear all
Page 1
Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial.
Moreno L, Weston R, Owens C, Valteau-Couanet D, Gambart M, Castel V, Zwaan CM, Nysom K, Gerber N, Castellano A, Laureys G, Ladenstein R, Rössler J, Makin G, Murphy D, Morland B, Vaidya S, Thebaud E, van Eijkelenburg N, Tweddle DA, Barone G, Tandonnet J, Corradini N, Chastagner P, Paillard C, Bautista FJ, Gallego Melcon S, De Wilde B, Marshall L, Gray J, Burchill SA, Schleiermacher G, Chesler L, Peet A, Leach MO, McHugh K, Hayes R, Jerome N, Caron H, Laidler J, Fenwick N, Holt G, Moroz V, Kearns P, Gates S, Pearson ADJ, Wheatley K; Innovative Therapies for Children with Cancer (ITCC) and European Association for Neuroblastoma Research (SIOPEN). Moreno L, et al. J Clin Oncol. 2024 Apr 1;42(10):1135-1145. doi: 10.1200/JCO.23.00458. Epub 2024 Jan 8. J Clin Oncol. 2024. PMID: 38190578 Free article. Clinical Trial.
Fibroblast growth factor.
Gospodarowicz D, Neufeld G, Schweigerer L. Gospodarowicz D, et al. Among authors: schweigerer l. Mol Cell Endocrinol. 1986 Aug;46(3):187-204. doi: 10.1016/0303-7207(86)90001-8. Mol Cell Endocrinol. 1986. PMID: 2427371 Review. No abstract available.
Phytoestrogens and inhibition of angiogenesis.
Fotsis T, Pepper MS, Montesano R, Aktas E, Breit S, Schweigerer L, Rasku S, Wähälä K, Adlercreutz H. Fotsis T, et al. Among authors: schweigerer l. Baillieres Clin Endocrinol Metab. 1998 Dec;12(4):649-66. doi: 10.1016/s0950-351x(98)80009-8. Baillieres Clin Endocrinol Metab. 1998. PMID: 10384818 Review.
Fibroblast growth factor: structural and biological properties.
Gospodarowicz D, Neufeld G, Schweigerer L. Gospodarowicz D, et al. Among authors: schweigerer l. J Cell Physiol Suppl. 1987;Suppl 5:15-26. doi: 10.1002/jcp.1041330405. J Cell Physiol Suppl. 1987. PMID: 2824530 Review.
Lymphangioblasts in embryonic lymphangiogenesis.
Wilting J, Tomarev SI, Christ B, Schweigerer L. Wilting J, et al. Among authors: schweigerer l. Lymphat Res Biol. 2003;1(1):33-40. doi: 10.1089/15396850360495673. Lymphat Res Biol. 2003. PMID: 15624319
Genotyping circulating tumor DNA of pediatric Hodgkin lymphoma.
Desch AK, Hartung K, Botzen A, Brobeil A, Rummel M, Kurch L, Georgi T, Jox T, Bielack S, Burdach S, Classen CF, Claviez A, Debatin KM, Ebinger M, Eggert A, Faber J, Flotho C, Frühwald M, Graf N, Jorch N, Kontny U, Kramm C, Kulozik A, Kühr J, Sykora KW, Metzler M, Müller HL, Nathrath M, Nüßlein T, Paulussen M, Pekrun A, Reinhardt D, Reinhard H, Rössig C, Sauerbrey A, Schlegel PG, Schneider DT, Scheurlen W, Schweigerer L, Simon T, Suttorp M, Vorwerk P, Schmitz R, Kluge R, Mauz-Körholz C, Körholz D, Gattenlöhner S, Bräuninger A. Desch AK, et al. Among authors: schweigerer l. Leukemia. 2020 Jan;34(1):151-166. doi: 10.1038/s41375-019-0541-6. Epub 2019 Aug 20. Leukemia. 2020. PMID: 31431735
98 results